Evidence map›Paper›PMID 30159161›Full record

ArticleCanadian journal of kidney health and disease2018

Cannabinoid Hyperemesis Syndrome Masquerading as Uremia: An Educational Case Report.

Judith Klassen, Gail Wilson

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian journal of kidney health and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. The nephrologist's guide to cannabis and cannabinoids.Current opinion in nephrology and hypertension · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Judith KlassenCollege of Medicine, Royal University Hospital, Royal University of Saskatchewan, Saskatoon, Canada.
Gail WilsonKidney Health, Saskatchewan Health Authority, Saskatoon, Canada.
Saskatchewan Health Authority · CAUniversity of Saskatchewan · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleWith marijuana legalization, clinicians need to be aware of Cannabinoid Hyperemesis Syndrome (CHS), which may masquerade as other disease states such as uremia. PRESENTING CONCERNS OF THE PATIENT: A 37-year-old man with bipolar affective disease treated with lithium had progressive renal insufficiency presumably on the basis of interstitial fibrosis. He developed persistent and severe nausea and vomiting which was assumed to be on the basis of uremia. Predating the nausea and vomiting was a history of daily marijuana use. DIAGNOSES: Renal insufficiency, bipolar affective disease, and intractable nausea and vomiting.

interventionsDialysis was initiated but did not improve his symptoms and multiple investigations revealed no other cause. Abstinence from marijuana use resulted in complete resolution of symptoms. OUTCOMES: The patient elected to discontinue dialysis and was still alive 7 months later. We concluded the nausea and vomiting were not on a uremic basis but more likely due to CHS. LESSONS LEARNED: With more widespread use of marijuana, it is important to be aware of CHS, which may be confused with uremia in patients with concomitant renal insufficiency.

Indexed as

cannabinoid hyperemesis syndromemarijuanarenal insufficiencyuremia

Identifiers

PMID30159161
PMCPMC6109838
OpenAlexW2888663029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.